178 related articles for article (PubMed ID: 29326282)
1. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
[No Abstract] [Full Text] [Related]
2. Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors.
Pan Y; Yang Y; Huang R; Yang H; Huang Q; Ji Y; Dai J; Qiao K; Tang W; Xie L; Yin M; Ouyang J; Ning S; Su D
Breast Cancer Res; 2022 Dec; 24(1):92. PubMed ID: 36539893
[TBL] [Abstract][Full Text] [Related]
3. High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer.
Wang C; Wen A; Qiao J; Liu Y; Guo Y; Wang W
Med Sci Monit; 2020 Apr; 26():e921370. PubMed ID: 32254065
[TBL] [Abstract][Full Text] [Related]
4. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation.
Zhi X; Zhao D; Wang Z; Zhou Z; Wang C; Chen W; Liu R; Chen C
Cancer Res; 2013 Jan; 73(1):385-94. PubMed ID: 23026136
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
[TBL] [Abstract][Full Text] [Related]
7. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
Wang Y; Deng O; Feng Z; Du Z; Xiong X; Lai J; Yang X; Xu M; Wang H; Taylor D; Yan C; Chen C; Difeo A; Ma Z; Zhang J
Oncogene; 2016 Mar; 35(11):1363-72. PubMed ID: 26234677
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of RNF126 is associated with poor prognosis and contributes to the progression of lung adenocarcinoma.
Sun Z; Liu X; Chen M; Zhang H; Zeng X
Biomark Med; 2021 Oct; 15(15):1345-1355. PubMed ID: 34533052
[No Abstract] [Full Text] [Related]
9. RNF126 as a Marker of Prognosis and Proliferation of Gastric Cancer.
Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Anticancer Res; 2020 Mar; 40(3):1367-1374. PubMed ID: 32132033
[TBL] [Abstract][Full Text] [Related]
10. E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer.
Wang L; Wang X; Zhao Y; Niu W; Ma G; Yin W; Shi C
Cancer Med; 2016 Aug; 5(8):2043-7. PubMed ID: 27227488
[TBL] [Abstract][Full Text] [Related]
11. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
[TBL] [Abstract][Full Text] [Related]
12. Ring finger protein 126: a potential biomarker for colorectal cancer.
Huang C; Min Y; Liu J; Li J; Yang X
Histol Histopathol; 2021 May; 36(5):559-566. PubMed ID: 33724438
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer.
Alcaraz-Sanabria A; Nieto-Jiménez C; Corrales-Sánchez V; Serrano-Oviedo L; Andrés-Pretel F; Montero JC; Burgos M; Llopis J; Galán-Moya EM; Pandiella A; Ocaña A
Mol Cancer Ther; 2017 Nov; 16(11):2552-2562. PubMed ID: 28847989
[TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
Smith CJ; Berry DM; McGlade CJ
J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
[TBL] [Abstract][Full Text] [Related]
15. p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.
Göhring UJ; Bersch A; Becker M; Neuhaus W; Schöndorf T
J Clin Pathol; 2001 Nov; 54(11):866-70. PubMed ID: 11684722
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome.
Jia L; Yang X; Tian W; Guo S; Huang W; Zhao W
Med Sci Monit; 2018 Nov; 24():8239-8249. PubMed ID: 30444219
[TBL] [Abstract][Full Text] [Related]
17. Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Shen JP; Srivas R; Gross A; Li J; Jaehnig EJ; Sun SM; Bojorquez-Gomez A; Licon K; Sivaganesh V; Xu JL; Klepper K; Yeerna H; Pekin D; Qiu CP; van Attikum H; Sobol RW; Ideker T
Oncotarget; 2015 Nov; 6(34):35755-69. PubMed ID: 26437225
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
19. Strong Correlation between the Expression of CHEK1 and Clinicopathological Features of Patients with Multiple Myeloma.
Liu XP; Huang Q; Yin XH; Meng XY; Cao Y; Yan XH; He L
Crit Rev Eukaryot Gene Expr; 2020; 30(4):349-357. PubMed ID: 32894664
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
